ITM Isotope Technologies Munich Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
350
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
9
- Investments
-
3
ITM Isotope Technologies Munich General Information
Description
Operator of a radiopharmaceutical biotech company intended to improve the treatment outcome of cancer patients. The company offers medical radioisotopes, a new generation of targeted cancer diagnostics and therapies, and precision oncology technologies to patients, therapeutic radiopharmaceutical clinicians, and healthcare partners, enabling nuclear medicine to reach its full potential for helping patients live longer and better.
Contact Information
Website
www.itm-radiopharma.comCorporate Office
- Walther-von-Dyck-Strasse 4
- 85748 Munich
- Germany
Corporate Office
- Walther-von-Dyck-Strasse 4
- 85748 Munich
- Germany
ITM Isotope Technologies Munich Timeline
ITM Isotope Technologies Munich Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ITM Isotope Technologies Munich Comparisons
Industry
Financing
Details
ITM Isotope Technologies Munich Competitors (34)
One of ITM Isotope Technologies Munich’s 34 competitors is Navidea Biopharmaceuticals, a Corporation company based in Dublin, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Navidea Biopharmaceuticals | Corporation | Dublin, OH | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Ability Pharma | Private Equity-Backed | Barcelona, Spain | ||||
| Bridge Medicines | Venture Capital-Backed | New York, NY | ||||
| NeoTherma Oncology | Venture Capital-Backed | Wichita, KS |
ITM Isotope Technologies Munich Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ITM Isotope Technologies Munich Patents
ITM Isotope Technologies Munich Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023262181-A1 | Combination treatment of small-cell lung cancer | Pending | 27-Apr-2022 | ||
| CA-3172480-A1 | Combination treatment of small-cell lung cancer | Pending | 27-Apr-2022 | ||
| EP-4514405-A1 | Combination treatment of small-cell lung cancer | Pending | 27-Apr-2022 | ||
| AU-2022258486-A1 | Radiopharmaceuticals at different activity reference times | Active | 13-Apr-2021 | ||
| CA-3213588-A1 | Radiopharmaceuticals to different arts | Pending | 13-Apr-2021 | A61K51/088 |
ITM Isotope Technologies Munich Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ITM Isotope Technologies Munich Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ITM Isotope Technologies Munich Investments (3)
ITM Isotope Technologies Munich’s most recent deal was a Joint Venture with Actineer. The deal was made on 18-Oct-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Actineer | 18-Oct-2023 | Joint Venture | Monitoring Equipment | ||
| Positron Precision | 18-Aug-2022 | Buyout/LBO | Other Healthcare Technology Systems | ||
| Joint Venture (Chengdu Gaotong Isotope / ITM) | 13-Sep-2021 | Joint Venture | Pharmaceuticals |
ITM Isotope Technologies Munich FAQs
-
When was ITM Isotope Technologies Munich founded?
ITM Isotope Technologies Munich was founded in 2004.
-
Where is ITM Isotope Technologies Munich headquartered?
ITM Isotope Technologies Munich is headquartered in Munich, Germany.
-
What is the size of ITM Isotope Technologies Munich?
ITM Isotope Technologies Munich has 350 total employees.
-
What industry is ITM Isotope Technologies Munich in?
ITM Isotope Technologies Munich’s primary industry is Diagnostic Equipment.
-
Is ITM Isotope Technologies Munich a private or public company?
ITM Isotope Technologies Munich is a Private company.
-
What is ITM Isotope Technologies Munich’s current revenue?
The current revenue for ITM Isotope Technologies Munich is .
-
How much funding has ITM Isotope Technologies Munich raised over time?
ITM Isotope Technologies Munich has raised $615M.
-
Who are ITM Isotope Technologies Munich’s investors?
Petrichor Healthcare Capital Management, RV Invest, Athos (Family Office), BlackRock, and Carbyne Equity Partners are 5 of 12 investors who have invested in ITM Isotope Technologies Munich.
-
Who are ITM Isotope Technologies Munich’s competitors?
Navidea Biopharmaceuticals, Genentech, Ability Pharma, Bridge Medicines, and NeoTherma Oncology are some of the 34 competitors of ITM Isotope Technologies Munich.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
